Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer

Chenyang Wang; Jing Li; Weina Liu; Shiya Li; Yi Zhang; Yanbin Jin; Jinquan Cui

doi:doi:10.18632/aging.204994

← Back

Research Paper Volume 15, Issue 17 pp 8744—8769

Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer

Figure 9. Co-expression between CLCN4 expression and certain genes. (A) DNA methyltransferase genes. (B) MMR genes. (C) immunostimulatory genes. (D) chemokine genes. (E) copper death gene. ^*p < 0.05, ^**p < 0.01, ^***p < 0.001.